1 |
K. Inada, T. Wakuda, and K. Uekawa, 'Prostaglandins and their cyclodextrin complexes,' J. Inclusion Phenomena, vol. 2, pp.467-474, 1984
DOI
|
2 |
H. Adachi, T. Irie, K. Uekawa, T. Manako, T. Yano and M. Saita 'Combination effects of O-carboxymethyl-O-ethyl--cyclodextrin and penetration enhancer HPE-101 on transdermal delivery of prostaglandin E1 in hairless mice,' Euro. J Pharma. Sci., vol. 1, no.3, pp.117-123, 1993
DOI
ScienceOn
|
3 |
K. Kalyanasundaram and J. K. Thomas, 'Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems,' J. Am. Chem. Soc. vol. 99, no. 7, pp.2039-2044, 1977
DOI
|
4 |
C. W. Lee, 'Drug-release behavior of polymeric prodrugs of ibuprofen with PEG and its derivatives as polymeric carriers,' Macromol. Res., vol. 12, no. 1, pp.71-77, 2004
DOI
|
5 |
C. Maltesh, Q. Xu, P. Somasundaran, W. J. Benton, and H. Nguyen, 'Aggregation behavior of and surface tension reduction by comb like amphiphilic polymers,' Langmuir, vol. 8, no. 6, pp.1511-1513, 1992
DOI
|
6 |
C. G. Overberger, Y. Inaki, and Y. Nambu, 'Graft copolymers of nucleic acid bases on po1yethy1eneimine: Interaction of the polymers,' J. Polymer Sci. Polymer Chem. Ed, vol. 17, pp. 1759-1769, 1979
DOI
|
7 |
C. G. Overberger, Y. Inaki, and Y. Nambu, 'Graft copolymers containing nucleic acid based and L-amino acids,' J. Polymer Sci. Polymer Chem. Ed, vol. 17, pp.1739-1758, 1979
DOI
|
8 |
C. W. Lee, 'Synthesis of various polymeric prodrugs of ibuprofen with PEG and its derivative as polymeric carriers,' Macromol. Res., vol. 12, no. 1, pp.63-70, 2004
DOI
|
9 |
H. jacobs and S. W. Kim, 'In vitro bioactivity of a synthesized prostaglandin E1-Heparin conjugate,' J. Pharm. Sci., vol. 75, no. 2, pp.172-181, 1986
DOI
|
10 |
C. W. Lee and Y. Kimura, 'In vitro biodegradability and surface properties of block copoly(ester-ether)s consisting of poly (L-Iactide) and polyether,' Macromol. Res., vol. 11, no. 1, pp42-46, 2003
DOI
|
11 |
R. Igarashi, Y. Mizushima, M. Takenaga, K. Matsumoto, Y. Morizawa, and A. Yasuda, 'A stable PGE1 prodrug for targeting therapy,' J. Controlled Release, vol. 20, no. 1, pp.37-45, 1992
DOI
ScienceOn
|
12 |
O. Vorobyova, A. Yekta, and M. A. Winnik, 'Fluorescent probe studies of the association in an aqueous solution of a hydrophobically modified poly(ethylene oxide),' Macromolecules, vol. 31, no. 25, pp.8998-9007, 1998
DOI
ScienceOn
|
13 |
C. W. Lee, 'Synthesis and properties of multiblock copolymers consisting of oligo(L-lactic acid) and poly(oxyethylene-co-oxypropylene) with different composition,' Korea Polym. J., vol. 9, no. 5, pp.259-266, 2001
|
14 |
H. Jacobs, T. Okano, J. T. Lin, and S. W. Kim, 'PGE1 Heparin conjugate releasing polymers,' J. Controlled Release, vol. 2, pp.313-319, 1985
DOI
ScienceOn
|
15 |
M. Hashida, K. Akamatsu, M. Nishikawa, F. Yamashita, H. Yashikawa, and Y. Takakura, 'Design of polymeric prodrugs of prostaglandin E1 having galactose residue for hepatocyte targeting,' J. Controlled Release, vol. 62, no. 1, pp.253-262, 1999
DOI
ScienceOn
|
16 |
K. D. Altmann, D. Husken, B. Cuenoud, and C. G. Echeverria 'Synthesis and hybridization properties of polyamide based nucleic acid analogues incorporating pyrrolidine-derived nucleoamino acids,' Bioorg. Med. Chem. Lett, vol. 10, pp.929-933, 2000
DOI
ScienceOn
|